PMID- 32944198
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220416
IS  - 2001-6689 (Print)
IS  - 2001-6689 (Electronic)
IS  - 2001-6689 (Linking)
VI  - 8
IP  - 1
DP  - 2020 Jun 17
TI  - Health-related quality of life of patients after ischaemic stroke treated in a 
      provincial hospital in Poland.
PG  - 1775933
LID - 10.1080/20016689.2020.1775933 [doi]
LID - 1775933
AB  - BACKGROUND: Ischaemic stroke (IS) is a major cause of death and disability and 
      affects the quality of life of patients. Previous studies focused on urban 
      populations. OBJECTIVE: To evaluate the health-related quality of life (QoL) of 
      patients with history of IS and living in a rural area in Poland. PATIENTS: Rural 
      population of 172 patients discharged from a district hospital in Zakopane, 
      Poland with a diagnosis of IS in the period from 01.01.2005 to 31.10.2006. 
      INTERVENTION: QoL was evaluated using the European Quality of Life Scale-5 
      Dimensions EQ-5D-3 L (EQ-5D) and the Short Form Health Survey - 12 version 2 
      (SF-12). RESULTS: In the EQ-5D survey, 57.3% of patients had only some problems 
      with mobility, 40.3% with usual activities, 63.2% with pain/discomfort, 59% with 
      anxiety/depression, and 32.2% with self-care. In the SF-12 survey, both summary 
      components (physical and psychological) were reduced compared to the population 
      norm. CONCLUSION: The quality of life in IS survivors is clearly reduced in the 
      majority of domains assessed by the EQ-5D and SF-12 questionnaires. The most 
      important factors affecting QoL were the functional state, depression and 
      anxiety. A significant difference as compared to to urban and mixed populations 
      was observed for a reduced SF-12 mental health component and for the EQ-5D visual 
      analogue scale. We found no effect of gender, age or cognitive disorders on the 
      outcomes of SF-12.
CI  - (c) 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & 
      Francis Group.
FAU - Jaroslawski, Szymon
AU  - Jaroslawski S
AD  - Public Health Department - Research Unit EA 3279, Aix-Marseille University, 
      Marseille, France.
FAU - Jaroslawska, Bozena
AU  - Jaroslawska B
AUID- ORCID: 0000-0003-4808-9772
AD  - Dr. T. Chalubinski District Hospital, Zakopane, Poland.
FAU - Blaszczyk, Barbara
AU  - Blaszczyk B
AD  - Private Neurology Practice, Kielce, Poland.
FAU - Auqier, Pascal
AU  - Auqier P
AD  - Public Health Department - Research Unit EA 3279, Aix-Marseille University, 
      Marseille, France.
FAU - Toumi, Mondher
AU  - Toumi M
AUID- ORCID: 0000-0001-7939-7204
AD  - Public Health Department - Research Unit EA 3279, Aix-Marseille University, 
      Marseille, France.
LA  - eng
PT  - Journal Article
DEP - 20200617
PL  - Switzerland
TA  - J Mark Access Health Policy
JT  - Journal of market access & health policy
JID - 101670174
PMC - PMC7482738
OTO - NOTNLM
OT  - Stroke
OT  - anxiety
OT  - cognitive function
OT  - depression
OT  - quality of life
COIS- Authors declare no conflicts of interest or sources of funding related to the 
      topics presented in the article.
EDAT- 2020/09/19 06:00
MHDA- 2020/09/19 06:01
PMCR- 2020/06/17
CRDT- 2020/09/18 05:50
PHST- 2020/09/18 05:50 [entrez]
PHST- 2020/09/19 06:00 [pubmed]
PHST- 2020/09/19 06:01 [medline]
PHST- 2020/06/17 00:00 [pmc-release]
AID - 1775933 [pii]
AID - 10.1080/20016689.2020.1775933 [doi]
PST - epublish
SO  - J Mark Access Health Policy. 2020 Jun 17;8(1):1775933. doi: 
      10.1080/20016689.2020.1775933.